Subject: Scientists Find Gene That Triggers Formation of Different Antibodies Date: Published: 12/22/89 (85 lines) Source: Wall Street Journal. Copyright Dow Jones & Co. Inc. Technology & Medicine: Scientists Find Gene That Triggers Formation of Different Antibodies ---- By David Stipp Staff Reporter of The Wall Street Journal CAMBRIDGE, Mass. -- Scientists here identified a gene that triggers the immune system's formation of different antibodies, a milestone in immune research. The finding sheds light on how the immune system responds to a myriad of different invading microbes, which has been "one of the great mysteries of biology," said David Baltimore, a Nobel laureate who directed the research at the Whitehead Institute of Biomedical Research, which is affiliated with Massachusetts Institute of Technology. While the discovery probably won't have near-term medical uses, the newly found gene provides a broadly useful tool for studying immune functions in infectious diseases and other disorders. The discovery concerns the process by which immune cells make antibodies, Y-shaped molecules that float in the blood looking for foreign microbes. The prongs of each antibody are shaped to fit a molecule on the surface of a specific invading micro-organism. Once an antibody latches onto a microbe, it attracts other immune molecules that destroy the invader. The latest discovery builds on two previous findings. In the 1970s, researchers discovered that immune cells called B cells combine a relatively small set of genes in different ways to create the genetic codes needed for millions of different antibody shapes. More recently, scientists found that immune cells called T cells employ a similar gene-shuffling process to make antibody-like molecules, called receptors, that they use to recognize foreign invaders. Now the Whitehead researchers have found that in both cases, the gene shuffling is activated by a single genetic master switch, which they isolated and named recombination activating gene No. 1, or RAG-1. The gene "is at the very heart of what makes the immune system go," said David G. Schatz, co-author of the study, which is reported in today's issue of the journal Cell. The researchers still don't know, however, whether RAG-1 triggers gene-shuffling directly or acts through intermediary genes. But with RAG-1 in hand, researchers can probe for gene recombination in different tissues. Cells in the olfactory system, for example, may shuffle genes to create many receptors for recognizing different odor molecules. By blocking RAG-1, scientists may be able to produce immune defects in animals that would elucidate similar defects in human diseases, said Marjorie A. Oettinger, another author of the study. The RAG-1 finding also may help researchers devise better ways to bolster the immune system in diseases such as acquired immune deficiency syndrome. Separately, researchers at the Whitehead Institute and at Johns Hopkins University reported that a previously discovered protein made by the AIDS virus may play an unexpected role in the disease's immune suppression. The finding concerns the transactivator, or TAT gene, of the AIDS virus. Scientists earlier discovered that it amplifies production of the AIDS virus within infected cells. In the latest finding, researchers found that the protein made by the gene may have a second, more direct damaging effect on the immune system. In test-tube studies, they showed that the protein lessened the ability of infection-fighting white blood cells to respond to invading microbes. "We think this is potentially very important to the process of the disease," said Alan D. Frankel, a Whitehead researcher and co-author of the study, which is reported in today's issue of the journal Science. He cautioned, however, that the TAT protein's immune suppression hasn't yet been established in animal or human studies. Moreover, the AIDS virus is known to damage the immune system in other ways, mainly by destroying a crucial subset of white blood cells called T4 cells. [This article is made available here by Dow Jones Co. for the personal and non-commercial use of callers to this bbs, in the hope that it will be of some help to those who are suffering from the disease and others who are seeking to help them.]